Get in touch today 206.598.4100 or

Schedule an Appointment

George Laramore, M.D., Ph.D., FACR, FASTRO

Professor

Locations of Practice

Seattle Children’s

4800 Sand Point Way NE
Seattle, WA 98105

Locate on Google Maps

SCCA Proton Therapy

1570 N 115th Street
Seattle, WA 98133

Locate on Google Maps

Overview

Dr. Laramore specializes in treating patients for salivary gland tumors, head and neck cancer, sarcoma of the soft tissue and bone, and genitourinary tumors particularly prostate cancer. Dr. Laramore practices at UWMC, Harborview, Seattle Children’s and SCCA Proton Therapy.

Patient Care Philosophy

“High-tech medicine can be adapted to the individual patient’s needs. I enjoy using the latest technological innovations in radiation oncology to design and carry out the optimal treatment for each patient. I am particularly interested in approaches that combine the benefits of radiotherapy with the use of chemotherapeutic agents or biological-response modifiers and in using genetic information to individualize patient treatment.”

Education and Training

College: Purdue University, West Lafayette, IN, 1965

Graduate School: PhD in Physics, University of Illinois, Urbana-Champaign, IL1969

Pre/Post-doctoral in physics: University of Illinois, funded by the National Science Foundation, 1970

Medical Education: University of Miami School of Medicine, Miami, FL, 1976

Residency: University of Washington School of Medicine, Radiation Oncology, Seattle, WA, 1978

Fellowship: American Cancer Society Clinical Fellow, 1980

Published Works

Liao JJ, Parvathaneni U, Laramore GE, Thompson JA, Bhatia S, Futran ND, Bhrany AD, Hawes SE, Ladra M. Fast neutron radiotherapy for primary mucosal melanomas of the head and neck. Head Neck. 2013 Jul 12

Gensheimer MF, Rainey D, Douglas JG, Liao JJ, Laramore GE, Jian-Amadi A, Chow LQ, Koh WJ, Parvathaneni U. Neutron radiotherapy for adenoid cystic carcinoma of the lacrimal gland. Ophthal Plast Reconstr Surg. 2013 Jul-Aug;29(4):256-60

Johnson B, Sales L, Winston A, Liao J, Laramore G, Parvathaneni U. Fabrication of customized tongue-displacing stents: considerations for use in patients receiving head and neck radiotherapy. J Am Dent Assoc. 2013 Jun;144(6):594-600

Wong WM, Parvathaneni U, Jewell PD, Martins RG, Futran ND, Laramore GE, Liao JJ. Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: a case report and review of the literature. Head Neck. 2013 Oct;35(10):E292-8

Parvathaneni U, Laramore GE, Liao JJ. Technical advances and pitfalls in head and neck radiotherapy. J Oncol. 2012;2012:597467

Laramore GE. Neutron radiotherapy in South Africa: neutron radiotherapy: a different perspective. S Afr Med J. 2012 Mar 23;102(5):269

Phillips MH, Smith WP, Parvathaneni U, Laramore GE. Role of positron emission tomography in the treatment of occult disease in head-and-neck cancer: a modeling approach. Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1089-95

Board Certification

American Board of Radiology, Therapeutic Radiology, 1980

American Board of Radiology, Radiation Oncology, 2000 and 2010